1. Date of the board of directors resolution:2025/11/10
2. Name and title of the managerial officer with permission to engage in
   competitive conduct:

(1) Vice President Yen-Chen Huang

(2)Vice President Hui-Yuan Kuo

(3)Associate Vice Presiden Shin-Ting Hsu

3. Items of competitive conduct in which the officer is permitted to engage:

(1)Vice President Yen-Chen Huang
Items of permitted to engage:Independent director, Elixiron Immunotherapeutics Inc.

(2)Vice President Hui-Yuan Kuo
Items of permitted to engage:Consultant, Oneness Biotech Co., Ltd.

(3)Associate Vice Presiden Shin-Ting Hsu
Items of permitted to engage:Director, StemCyte Taiwan Co., Ltd.

4. Period of permission to engage in the competitive conduct:
   During the individual’s tenure as a manager of the Company.
5. Circumstances of the resolution (please describe the results of voting in accordance with Article 32 of the Company Act):
   All Directors present unanimously approved the proposal.
6. If the permitted competitive conduct belongs to the operator of a mainland China area enterprise, the name and title of the managerial officer (if it is not the operator of a mainland China area enterprise, please enter“N/A” below):N/A
7. Company name of the mainland China area enterprise and the officer’s position in the enterprise:N/A
8. Address of the mainland China area enterprise:N/A
9. Operations of the mainland China area enterprise:N/A
10. Impact on the company’s finance and business:None
11. If the managerial officer has invested in the mainland China area enterprise, the monetary amount of the investment and the officer’s shareholding ratio:None
12. Any other matters that need to be specified:None